Placental protein 5 in gestational trophoblastic disease: Localization and circulating levels

Andrew D. Nisbet, Roy D. Bremner, Charles H.W. Horne, Doris Brooker, Leo B. Twiggs, Takashi Okagaki

Research output: Contribution to journalArticle

4 Scopus citations

Abstract

With the use of an indirect immunoperoxidase technique (peroxidase-antiperoxidase) placental protein 5 (PP5) has been shown to be present in a high percentage of gestational trophoblastic tumors, especially the better differentiated ones. By sensitive radioimmunoassay, PP5 has further been found to be present in sera from patients with persistent gestational trophoblastic disease but not to the same frequency or extent as human chorionic gonadotropin. The only finding of clinical importance was the association in one case of high levels of PP5 and concurrent intravascular coagulation.

Original languageEnglish (US)
Pages (from-to)396-401
Number of pages6
JournalAmerican journal of obstetrics and gynecology
Volume144
Issue number4
DOIs
StatePublished - Oct 15 1982

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'Placental protein 5 in gestational trophoblastic disease: Localization and circulating levels'. Together they form a unique fingerprint.

  • Cite this